These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 8416736

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Production of monoclonal antibodies specific for ganglioside GD3.
    Watarai S, Onuma M, Yasuda T.
    J Biochem; 1991 Dec; 110(6):889-95. PubMed ID: 1724444
    [Abstract] [Full Text] [Related]

  • 25. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
    Hofmann UB, Westphal JR, Waas ET, Zendman AJ, Cornelissen IM, Ruiter DJ, van Muijen GN.
    Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors.
    Scott AM, Geleick D, Rubira M, Clarke K, Nice EC, Smyth FE, Stockert E, Richards EC, Carr FJ, Harris WJ, Armour KL, Rood J, Kypridis A, Kronina V, Murphy R, Lee FT, Liu Z, Kitamura K, Ritter G, Laughton K, Hoffman E, Burgess AW, Old LJ.
    Cancer Res; 2000 Jun 15; 60(12):3254-61. PubMed ID: 10866319
    [Abstract] [Full Text] [Related]

  • 31. Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen.
    Stinson SF, Alley MC, Kopp WC, Fiebig HH, Mullendore LA, Pittman AF, Kenney S, Keller J, Boyd MR.
    Anticancer Res; 1992 Jun 15; 12(4):1035-53. PubMed ID: 1503399
    [Abstract] [Full Text] [Related]

  • 32. Production of monoclonal antibodies directed to Hanganutziu-Deicher active gangliosides, N-glycolylneuraminic acid-containing gangliosides.
    Watarai S, Kushi Y, Shigeto R, Misawa N, Eishi Y, Handa S, Yasuda T.
    J Biochem; 1995 May 15; 117(5):1062-9. PubMed ID: 8586620
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production.
    Zeng G, Gao L, Birklé S, Yu RK.
    Cancer Res; 2000 Dec 01; 60(23):6670-6. PubMed ID: 11118051
    [Abstract] [Full Text] [Related]

  • 35. Reducing epitope spread during affinity maturation of an anti-ganglioside GD2 antibody.
    Hu J, Huang X, Ling CC, Bundle DR, Cheung NK.
    J Immunol; 2009 Nov 01; 183(9):5748-55. PubMed ID: 19812201
    [Abstract] [Full Text] [Related]

  • 36. Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas.
    Longee DC, Wikstrand CJ, Månsson JE, He X, Fuller GN, Bigner SH, Fredman P, Svennerholm L, Bigner DD.
    Acta Neuropathol; 1991 Nov 01; 82(1):45-54. PubMed ID: 1659106
    [Abstract] [Full Text] [Related]

  • 37. Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII.
    Wikstrand CJ, McLendon RE, Friedman AH, Bigner DD.
    Cancer Res; 1997 Sep 15; 57(18):4130-40. PubMed ID: 9307304
    [Abstract] [Full Text] [Related]

  • 38. GD3 expression by cultured human tumor cells of neuroectodermal origin.
    He X, Wikstrand CJ, Fredman P, Månsson JE, Svennerholm L, Bigner DD.
    Acta Neuropathol; 1989 Sep 15; 79(3):317-25. PubMed ID: 2609939
    [Abstract] [Full Text] [Related]

  • 39. Monoclonal antibodies to malignant human gliomas.
    Wikstrand CJ, Fredman P, Svennerholm L, Humphrey PA, Bigner SH, Bigner DD.
    Mol Chem Neuropathol; 1992 Oct 15; 17(2):137-46. PubMed ID: 1384525
    [Abstract] [Full Text] [Related]

  • 40. Affinity-matured recombinant immunotoxin targeting gangliosides 3'-isoLM1 and 3',6'-isoLD1 on malignant gliomas.
    Piao H, Kuan CT, Chandramohan V, Keir ST, Pegram CN, Bao X, Månsson JE, Pastan IH, Bigner DD.
    MAbs; 2013 Oct 15; 5(5):748-62. PubMed ID: 23924792
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.